SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2022-03-04 17:45
Tx date 2022-03-01
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+500,000 vol
750,000
Filed 2022-03-04 17:44
Tx date 2021-06-30
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-145,655 vol
250,000
Filed 2022-03-04 17:43
Tx date 2021-02-22
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-130,000 vol
395,655
Filed 2021-12-08 18:13
Tx date 2021-12-07
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$91,196
+325,700 vol
$0.28 each
4,001,563
Filed 2020-12-17 18:13
Tx date 2020-12-09
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$154,000
+200,000 vol
$0.77 each
525,655
Filed 2020-09-10 00:29
Tx date 2020-09-04
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$450,073
+145,655 vol
$3.09 each
325,655
Filed 2020-09-10 00:27
Tx date 2020-06-29
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-1,620,000 vol
180,000
Filed 2020-09-10 00:21
Tx date 2020-06-29
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation

-337,500 vol
37,500
Filed 2020-09-10 00:19
Tx date 2020-09-04
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+1,925,863 vol
3,675,863
Filed 2020-09-10 00:18
Tx date 2020-06-29
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-15,750,000 vol
1,750,000
Filed 2020-09-10 00:17
Tx date 2020-09-04
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Khadija Zerouali (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+895,750 vol
1,175,304
Filed 2020-09-10 00:16
Tx date 2020-06-29
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Khadija Zerouali (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-2,515,987 vol
279,554
Filed 2020-09-10 00:13
Tx date 2020-06-29
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-2,736,000 vol
303,950
Filed 2020-05-31 18:27
Tx date 2020-05-31
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
99 - Correction of information

-350,460 vol
17,500,000
Filed 2020-05-31 18:26
Tx date 2019-06-04
$BETR
Pivot Pharmaceuticals Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

+2,873,562 vol
20,646,001
Filed 2020-05-31 18:25
Tx date 2020-05-31
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Khadija Zerouali (Indirect Ownership)
Common Shares
99 - Correction of information

-284,000 vol
2,795,541
Filed 2020-05-31 18:20
Tx date 2018-10-30
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Kinwa Pharma International Company Ltd. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately

-200,000 vol
0
Filed 2020-05-31 18:15
Tx date 2019-06-04
$BETR
Pivot Pharmaceuticals Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

+2,523,102 vol
Filed 2020-05-31 18:12
Tx date 2018-10-30
$BETR
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately

-225,000 vol
3,039,950
Filed 2019-06-07 11:10
Tx date 2019-06-04
$BETR
Pivot Pharmaceuticals Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

+2,873,562 vol
Filed 2018-11-01 00:48
Tx date 2018-10-30
$BETR
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately

-25,000 vol
Filed 2020-05-15 17:35
Tx date 2020-05-07
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$90,000
+500,000 vol
$0.18 each
1,800,000
Filed 2020-01-30 18:25
Tx date 2019-12-23
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

-2,795,541 vol
17,850,460
Filed 2020-01-30 18:23
Tx date 2019-12-23
$BETR
BetterLife Pharma Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Khadija Zerouali (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately

+2,795,541 vol
3,079,541
Filed 2019-06-17 15:21
Tx date 2019-06-12
$PVOT
Pivot Pharmaceuticals Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
$-490,000
-700,000 vol
$0.70 each
1,300,000
Filed 2019-06-07 11:10
Tx date 2019-06-04
$PVOT
Pivot Pharmaceuticals Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

+2,873,562 vol
20,646,001
Filed 2019-06-05 14:12
Tx date 2018-10-22
$PVOT
Pivot Pharmaceuticals Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+375,000 vol
375,000
Filed 2019-06-05 14:10
Tx date 2010-03-18
$PVOT
Pivot Pharmaceuticals Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-24 16:16
Tx date 2019-05-15
$PVOT
Pivot Pharmaceuticals Inc.
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$-50,000
-200,000 vol
$0.25 each
17,772,439
Filed 2018-11-01
Tx date 2018-03-05
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately

-1,200,000 vol
Filed 2018-11-01
Tx date 2018-03-02
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately

-1,200,000 vol
3,264,950
Filed 2018-11-01
Tx date 2018-03-05
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately

-1,200,000 vol
Filed 2018-11-01
Tx date 2018-10-30
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately

-25,000 vol
3,239,950
Filed 2018-10-27
Tx date 2018-10-22
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$150,000
+375,000 vol
$0.40 each
17,972,439
Filed 2018-05-21
Tx date 2018-05-15
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$76,440
+136,500 vol
$0.56 each
17,597,439
Filed 2018-04-05
Tx date 2018-04-02
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Khadija Zerouali (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$37,380
+42,000 vol
$0.89 each
284,000
Filed 2018-04-05
Tx date 2018-04-02
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$54,450
+55,000 vol
$0.99 each
17,460,939
Filed 2018-03-09
Tx date 2018-03-05
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately

-1,200,000 vol
3,264,950
Filed 2018-03-07
Tx date 2018-03-02
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
OTC Puts (including Private Options to Sell) Expiry March 2, 2021
70 - Acquisition or disposition (writing) of third party derivative
$1.40
+2 vol
$0.70 each
2
Filed 2018-03-07
Tx date 2010-03-18
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
OTC Puts (including Private Options to Sell) Expiry March 2, 2021
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-01
Tx date 2018-02-26
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Khadija Zerouali (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market

+42,000 vol
242,000
Filed 2018-03-01
Tx date 2018-02-26
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+20,000 vol
20,279,501
Filed 2018-02-28
Tx date 2018-02-28
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

-2,873,562 vol
17,385,939
Filed 2018-02-28
Tx date 2018-02-27
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

-2,747,252 vol
Filed 2018-01-22
Tx date 2018-01-16
$PVOT
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
$-240,000
-300,000 vol
$0.80 each
4,464,950
Filed 2017-12-14
Tx date 2012-07-29
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants Expiry Date July 29, 2012
55 - Expiration of warrants
$-2,500
-500,000 vol
$0.005 each
0
Filed 2017-12-14
Tx date 2016-02-23
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,400,000
+2,000,000 vol
$0.70 each
2,000,000
Filed 2017-12-14
Tx date 2015-05-25
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-4,000
-800,000 vol
$0.005 each
0
Filed 2017-12-14
Tx date 2015-01-21
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-4,000
-800,000 vol
$0.005 each
800,000
Filed 2017-12-14
Tx date 2015-04-15
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Kinwa Pharma International Company Ltd. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-1,800,000 vol
200,000
Filed 2017-12-14
Tx date 2015-04-15
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Khadija Zerouali (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-1,800,000 vol
200,000
Filed 2017-12-14
Tx date 2015-04-15
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-182,675,711 vol
20,259,501
Filed 2017-12-14
Tx date 2015-01-15
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
97 - Other
$16,512,521
+165,125,212 vol
$0.10 each
202,935,212
Filed 2017-12-14
Tx date 2013-09-24
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
97 - Other
$35,000
+35,000,000 vol
$0.001 each
37,810,000
Filed 2017-12-14
Tx date 2015-04-15
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Control or Direction)
Common Shares
37 - Stock split or consolidation

-42,884,550 vol
4,764,950
Filed 2017-12-14
Tx date 2015-03-06
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Control or Direction)
Common Shares
97 - Other
$47,649
+47,649,500 vol
$0.001 each
47,649,500
Filed 2017-12-14
Tx date 2010-03-18
$PVOTF
Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.)
Doroudian, Ahmad
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Sassel Investments Inc. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report